Hologic Inc (NASDAQ: HOLX)

Hologic Inc., often recognized by its stock symbol HOLX, is a prominent player in the medical technology industry, specializing in diagnostics products, medical imaging systems, and surgical products that cater to women's health and well-being through early detection and treatment. The company's operations are divided into four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.

Hologic's main business activities revolve around the development, manufacturing, and supply of premium diagnostics products, medical imaging systems, and surgical products. These products are designed to aid healthcare providers in the early detection and treatment of various health conditions, particularly those related to women's health. The company's operations span across multiple countries and regions, with a broad customer base that includes hospitals, clinics, private practices, government agencies, and research institutions.

Revenue for Hologic is primarily generated through the sales of its diagnostic products, medical imaging systems, and surgical products. In the Diagnostics segment, the company offers a wide range of diagnostic products, including molecular diagnostic assays that run on advanced instrumentation systems like the Panther, Panther Fusion, and Tigris systems. These assays are used to detect a variety of diseases, ranging from sexually transmitted diseases to Hepatitis B and C viruses. Hologic has also developed and launched assays for the detection of respiratory infections, including the Aptima SARS-CoV-2 assay and the Aptima SARS-CoV-2/Flu assay.